Edition:
United States

Laboratorios Farmaceuticos ROVI SA (ROVI.MC)

ROVI.MC on Madrid SE C.A.T.S.

16.60EUR
8 Dec 2017
Change (% chg)

€-0.21 (-1.25%)
Prev Close
€16.81
Open
€16.90
Day's High
€17.00
Day's Low
€16.50
Volume
9,380
Avg. Vol
3,822
52-wk High
€18.75
52-wk Low
€11.72

Chart for

About

Laboratorios Farmaceuticos ROVI SA (ROVI) is a Spain-based company principally engaged in the pharmaceutical industry. The Company’s main activities include the development and commercialization, nationwide and abroad, of medicines and drugs. Its products are structured into three fields: Diagnostic, which offers contrast... (more)

Overall

Beta: 0.50
Market Cap(Mil.): €841.50
Shares Outstanding(Mil.): 50.00
Dividend: 0.18
Yield (%): 1.09

Financials

  Industry Sector
P/E (TTM): -- 32.13 15.67
EPS (TTM): -- -- --
ROI: -- 15.10 34.62
ROE: -- 16.59 16.00

BRIEF-Rovi 9-month operating revenue up 6 pct at 203.4 mln euros YoY

* RECURRENT NET PROFIT DECREASED BY 4 PERCENT TO 17.0 MILLION EUROS IN 9-MONTH

Nov 08 2017

BRIEF-Rovi announces update on risperidone project

* ANNOUNCES UPDATE ON A PHASE III STUDY FOR A LONG-ACTING INJECTABLE (LAI) TO TREAT SCHIZOPHRENIA CALLED DORIA(PREVIOUSLY RISPERIDONE ISM)

Oct 24 2017

BRIEF-Rovi starts enoxaparin biosimilar marketing in Germany‍​

* SAYS STARTS ENOXAPARIN BIOSIMILAR MARKETING IN GERMANY‍​ Source text for Eikon:

Sep 07 2017

BRIEF-Rovi H1 Ebitda down 4 pct to 23.9 mln euros YoY

July 26 Laboratorios Farmaceuticos ROVI SA (ROVI):

Jul 26 2017

Earnings vs. Estimates